Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether aripiprazole augmentation is safe and
effective in the treatment of clozapine-treated patients with refractory schizophrenia.